INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/16/2025
Back to search
Official data from USPTO
CENTOBREAST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CENTOBREAST
ST13
US500000079193468Class
5, 42, 44
Filing
79193468
Registration
5337452
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/17/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/11/2016
Registration date
11/21/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/07/2024
Last transaction
05/17/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
DE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Centogene GmbH
Centogene AG
Representatives
Angela P. Doughty Ward and Smith, P. A.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparationstreated or untreated human biological specimens; Pharmaceutical and veterinary preparationspreparations for treatment with stabilizers that prevent degradation of nucleic acids; pharmaceutical and veterinary preparations comprising treated or untreated human biological specimensstabilizers preventing degradation of nucleic acids; chemical preparations for analyses in laboratoriesfor medical or veterinary purposesisolation and processing of nucleic acidswith chemicalsoligonucleotides and reagents for downstream sequencingchemical preparations comprising treated or untreated human biological specimens comprising isolated and/or processes nucleic acidsoptionally chemical compoundsoligonucleotides and/or reagents for downstream sequencing; cultures of microorganisms for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; biological preparations for medical purposesfor the treatment of hereditary diseasesoncological diseases and complex multigenic diseases; preparations for detecting genetic predispositions for medical purposes; nucleic acid sequences for medical and veterinary purposes
Class 42
Scientific and technological servicesscientific researchanalysis and testing in the field of oncological diseaseshereditary diseases and complex multigenic diseases; industrial analysis and research services in the field of oncological diseaseshereditary diseases and complex multigenic diseases; scientific research for medical purposes in the field of oncological diseaseshereditary diseases and complex multigenic diseases; research and development in the field of biotechnology; genetic engineering services; research and development in the field of diagnostics; design and development of medical diagnostic apparatus; design and development of computer hardwarecomputer software and databases; computer aided scientific research servicestesting and analysis services
Class 44
Medical and veterinary servicesin particular medical analysis in connection with the treatment of individuals; conducting of medical tests for diagnostic or treatment purposes; medical laboratory services for the analysis of samples taken from patientsmedical testing of bloodtissuesalivaurinelymph fluidliquorstool and hair follicle; providing information in the fields of medicineveterinary medicine and pharmacology
Publications
History of USPTO decisions and trademark events.
38 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/26/2025
INPC
INVALIDATION PROCESSED
04/26/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/07/2025
C71T
CANCELLED SECTION 71
06/07/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/21/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/18/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/26/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/13/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2018
FIMP
FINAL DISPOSITION PROCESSED
02/22/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2017
PUBO
PUBLISHED FOR OPPOSITION
09/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/31/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/31/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/31/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/31/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/08/2017
GNRT
NON-FINAL ACTION E-MAILED
06/08/2017
CNRT
NON-FINAL ACTION WRITTEN
06/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2017
ALIE
ASSIGNED TO LIE
05/17/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2016
RFNT
REFUSAL PROCESSED BY IB
11/18/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/28/2016
RFRR
REFUSAL PROCESSED BY MPU
10/28/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/19/2016
CNRT
NON-FINAL ACTION WRITTEN
10/18/2016
DOCK
ASSIGNED TO EXAMINER
10/18/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2016
Continuous trademark protection
Get notified about every new filing that threatens CENTOBREAST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.